Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of anti-arrhythmic effects of oral S44121 in chronic heart failure with ICD
2009-014940-12Phase 2Completed
- Sponsor
- Servier
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of S44121 in chronic heart failure (CHF), left ventricular systolic dysfunction (LVSD) and ventricular arrhythmia (VA) (4 arms), sponsored by Servier. Primary endpoint: Average rate of PVCs per hour during 48-hour Holter ECG recording. Started Jan 2010; status: completed.
02
Drugs
S44121
03
Conditions
chronic heart failure (CHF)left ventricular systolic dysfunction (LVSD)ventricular arrhythmia (VA)
Beyond the preview
Go deeper on 2009-014940-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014940-12.